Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.87 - $1.13 $545,025 - $707,906
-626,466 Reduced 75.82%
199,789 $177,000
Q2 2023

Aug 14, 2023

SELL
$0.81 - $1.15 $100,233 - $142,306
-123,745 Reduced 13.03%
826,255 $950,000
Q1 2023

May 15, 2023

SELL
$0.8 - $1.74 $60,000 - $130,500
-75,000 Reduced 7.32%
950,000 $798,000
Q4 2022

Feb 14, 2023

SELL
$1.09 - $20.4 $54,500 - $1.02 Million
-50,000 Reduced 4.65%
1,025,000 $1.33 Million
Q4 2021

Feb 14, 2022

BUY
$2.13 - $3.46 $479,250 - $778,500
225,000 Added 26.47%
1,075,000 $2.51 Million
Q3 2021

Nov 15, 2021

BUY
$3.14 - $3.9 $314,000 - $390,000
100,000 Added 13.33%
850,000 $2.96 Million
Q2 2021

Aug 16, 2021

BUY
$3.8 - $4.56 $494,000 - $592,800
130,000 Added 20.97%
750,000 $2.91 Million
Q1 2021

May 14, 2021

BUY
$4.33 - $6.63 $476,733 - $729,963
110,100 Added 21.59%
620,000 $2.85 Million
Q4 2020

Feb 12, 2021

BUY
$4.87 - $17.29 $2.48 Million - $8.82 Million
509,900 New
509,900 $3.09 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.